Antibody-drug Conjugates Archives - Onco'Zine

Home Tags Antibody-drug Conjugates

Seattle Genetics Rebrands itself as Seagen

Editorial Team - October 8, 2020

NBE-Therapeutics Signs Agreement with Exelixis to Advance ADCs Against Multiple Targets

Editorial Team - September 9, 2020

New Therapies may Offer Hope for Patients with Metastatic Breast Cancer

Peter Hofland, Ph.D - June 24, 2020

A doctor examines mammogram snapshot of breast of patient on the monitors.

Trastuzumab deruxtecan Launched in Japan for HER2+ Unresectable or Metastatic Breast...

Editorial Team - May 25, 2020

Doctor discussing treatment options with a patient.

RemeGen Initiates Clinical Trial for Distamab vedotin, a Novel anti-HER2 Antibody-drug...

Peter Hofland, Ph.D - May 1, 2020

The American Association for Cancer Research (AACR) Annual Meeting in pre-COVID19 Days: New Orleans, LA - The AACR 2016 Annual Meeting. Photo courtesy AACR/Scott Morgan.

STRO-002 Shows Encouraging Results in Phase I Trial in Treatment of...

Peter Hofland, Ph.D - April 27, 2020

Combination Enfortumab Vedotin + Pembrolizumab Granted Breakthrough Therapy in Bladder Cancer

Peter Hofland, Ph.D - February 19, 2020

Featured Image: Pink breast cancer awareness. Photo courtesy: 2019 Fotolia.

Trastuzumab deruxtecan Approved for the Treatment of Metastatic HER2-positive Breast Cancer

Peter Hofland, Ph.D - December 21, 2019

Doctor discussing treatment options with a patient.

FDA Approves Novel Treatments for Metastatic Urothelial Cancer – But More...

Andrea Maddox-Smith - December 20, 2019

Seattle Genetics. Exhibition booth during the 2019 annual meeting of the American Society of Medical Oncology (ASCO). In the back of the booth the enfortumab vedotin presentation.

FDA Approves New Drug for Advanced Bladder Cancer

Peter Hofland, Ph.D - December 19, 2019

12 3 4 Page 1 of 4

LATEST NEWS

AmunBio and NorthShore University to Advance Cancer Immunotherapy with Engineered Oncolytic Viruses

Peter Hofland, Ph.D - April 13, 2021

A Spaceship on Mars and Screening for Gynecologic Cancer

Valena Wrtight, MD - April 6, 2021

Are Cytology and Imaging Adequate for the Diagnostic Management of Brain Metastasis?

Michael C. Dugan, M.D. - April 1, 2021

Combination of SLC-391 + Pembrolizumab Enters Clinical Trial Advanced NSCLC

Peter Hofland, Ph.D - March 31, 2021

Revealing the Blind Spot in Cancer Treatment with Host Response Profiling

Ofer Sharon, MD, MBA - March 22, 2021

Press Releases | Cancer

HMP Global Announces Distinguished Faculty Lineup for Inaugural Great... April 14, 2021
Program features clinical insight from prominent experts in the fields of gynecological and breast cancers; two-day agenda will address hot topics in an interactive, engaging format(PRWeb April 14, 2021)Read the full story at https://www.prweb.com/releases/hmp_global_announces_distinguished_faculty_lineup_for_inaugural_great_debates_updates_in_womens_oncology/prweb17863195.htm
Personalized Cancer Vaccine Guided by Mount Sinai Computations Is... April 10, 2021
A personalized cancer vaccine developed with the help of a Mount Sinai computational platform raised no safety concerns and showed potential benefit in patients with different cancers, including lung...(PRWeb April 10, 2021)Read the full story at https://www.prweb.com/releases/personalized_cancer_vaccine_guided_by_mount_sinai_computations_is_safe_shows_potential_benefit_against_multiple_tumor_types/prweb17844223.htm
Olaris, Inc. Announces Presentation on Metabolic Biomarkers of... April 9, 2021
Olaris to present new data on metabolic signatures predictive of overall survival and therapeutic response in advanced GIST at upcoming AACR Virtual Meeting(PRWeb April 09, 2021)Read the full story at https://www.prweb.com/releases/olaris_inc_announces_presentation_on_metabolic_biomarkers_of_response_in_advanced_gist_at_american_association_for_cancer_research_aacr_2021_annual_meeting/prweb17852208.htm